Heightened systemic inflammation contributes to cardiovascular (CVD) events in people living with HIV (PLWH), although not all PLWH develop CVD, thus suggesting a genetic modifying role. We examined GCH1 polymorphisms, which have been associated with reduced endothelial function in European populations with CVD and increased inflammation, in a racially diverse cohort of US PLWH initiating antiretroviral therapy (ART). GCH1 polymorphisms differed by race and were not associated with flow-mediated dilation or carotid intima–media thickness before or after 48 weeks of ART.
aDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana
bDepartment of Medicine, Vanderbilt University, Nashville, Tennessee
cDepartment of Medicine, University of Wisconsin, Madison, Wisconsin
dDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland
eDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Correspondence to Dr Samir K. Gupta, Division of Infectious Diseases, Indiana University School of Medicine, Emerson Hall, Suite 421, 545 Barnhill Drive, Indianapolis, IN 46202, USA. Tel: +1 317 274 7926; fax: +1 317 274 1587; e-mail: firstname.lastname@example.org
Received 17 March, 2019
Revised 29 April, 2019
Accepted 29 April, 2019